The limitations of calcineurin and mTOR inhibitors: New directions for immunosuppressive strategies

被引:16
|
作者
Kahan, BD [1 ]
机构
[1] Univ Texas, Sch Med, Div Organ Transplantat, Dept Surg, Houston, TX 77030 USA
关键词
D O I
10.1016/S0041-1345(01)02702-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:130 / 133
页数:4
相关论文
共 50 条
  • [31] Adenosine Triphosphate-Competitive mTOR Inhibitors: A New Class of Immunosuppressive Agents That Inhibit Allograft Rejection
    Rosborough, B. R.
    Raich-Regue, D.
    Liu, Q.
    Venkataramanan, R.
    Turnquist, H. R.
    Thomson, A. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (09) : 2173 - 2180
  • [32] mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
    Jeong, Anna
    Wong, Michael
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (12)
  • [33] mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
    Anna Jeong
    Michael Wong
    Current Neurology and Neuroscience Reports, 2016, 16
  • [34] Functional heterogeneity of endothelial cell response to MTOR- and calcineurin-inhibitors
    Schreml, S
    Lehle, K
    Birnbaum, DE
    Preuner, JG
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 139 - 139
  • [35] Activation of renal profibrotic TGFβ controlled signaling cascades by calcineurin and mTOR inhibitors
    Eberhardt, Wolfgang
    Nasrullah, Usman
    Pfeilschifter, Josef
    CELLULAR SIGNALLING, 2018, 52 : 1 - 11
  • [36] Effects of Calcineurin Inhibitors and Implication of Efflux Transporters and CYP3A on the Intestinal Flux of mTOR Inhibitors
    Lamoureux, F.
    Picard, N.
    Sauvage, F. L.
    Marquet, P.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 657 - 658
  • [37] Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant
    José M álamo
    Claudia Olivares
    Lydia Barrera
    Luis M Marín
    Gonzalo Suarez
    Carmen Bernal
    Juan Serrano
    Jordi Muntané
    Francisco J Padillo
    Miguel A Gómez
    World Journal of Transplantation, 2015, 5 (01) : 19 - 25
  • [38] Case 2: Strategies to minimize the use of calcineurin inhibitors (CNIs)
    Hariharan, S
    TRANSPLANTATION, 2002, 74 (05) : 746 - 747
  • [39] Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model
    Zakerkish, F.
    Soriano, M. J.
    Novella-Mestre, E.
    Brannstrom, M.
    Diaz-Garcia, C.
    HUMAN REPRODUCTION OPEN, 2021, 2021 (02) : 1 - 10
  • [40] Nephrotoxicity of calcineurin inhibitors: New therapeutic approaches
    Abramowicz, D
    Wissing, KM
    Broeders, N
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (1A) : 3S - 5S